The Enzyme That Keeps Viruses In Stealth Mode

River D'Almeida, Ph.D
2 min readNov 12, 2020

Some viral infections just don’t go away. The hepatitis C virus, for instance, can result in life-long chronic infection if left untreated, leading to potentially life-threatening symptoms such as liver damage. In the case of such infections, why doesn’t the body’s immune system detect and eliminate such viruses?

Researchers at the University of Missouri School of Medicine have found another piece of the puzzle surrounding this question: an enzyme called sphingosine kinase 2, or SphK2, that allows viruses to remain in stealth mode, evading immune clearance. The findings, published in the Journal of Clinical Investigation, point to a promising therapeutic target to treat these persistent viral infections.

Senior author Bumsuk Hahm said, “There is very little research on how the sphingosine kinase 2 (SphK2) enzyme affects the immune responses to viral infections.”

“We hypothesized that this enzyme suppresses the T cells that fight infections and allows viruses to persist.”

The scientists used a mouse model of lymphocytic choriomeningitis virus infection to test this theory, a common virus affecting rodents. After being administered a pharmaceutical agent to temporarily suppress SphK2, the mice launched a strong immune response that attacked and removed the virus.

--

--

River D'Almeida, Ph.D
River D'Almeida, Ph.D

Written by River D'Almeida, Ph.D

Follow me for bite-sized stories on the latest discoveries and innovations in biomedical research.

No responses yet